{"id":"W4235489476","doi":"10.1002/art.41042","title":"2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","year":2019,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":631,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Toronto Western Hospital; University of Toronto","funders":"Spondyloarthritis Research and Treatment Network; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Spondylitis Association of America","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Ixekizumab; Discontinuation; Adalimumab; Psoriatic arthritis; Rheumatology; Infliximab; Etanercept; Rheumatoid arthritis; Tofacitinib; Internal medicine; Physical therapy; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03003907,0.001608005,0.004282777,0.0188191,0.001119225,0.003980897,0.003668934,0.003695545,0.01978704],"category_scores_gemma":[0.09079132,0.001391143,0.007174412,0.01091551,0.0006526156,0.002880676,0.003031342,0.004100847,0.007174056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007947636,"about_ca_system_score_gemma":0.03428499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0406962,"about_ca_topic_score_gemma":0.06770136,"domain_scores_codex":[0.9658313,0.00861235,0.01385863,0.001431056,0.009387659,0.0008791313],"domain_scores_gemma":[0.9148747,0.02019209,0.01755368,0.001536489,0.04339428,0.002448709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003309636,0.0001028293,0.002764302,0.08933827,0.002587951,0.0001626691,0.0003480599,0.0004884945,0.0005180689,0.002826779,0.5545529,0.3459787],"study_design_scores_gemma":[0.0006018214,0.0001225387,0.00913869,0.1520945,0.006698205,0.0003126024,0.0002125983,0.0003009491,0.0002393543,0.002237195,0.8279104,0.000131099],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002506576,0.7060223,0.008078274,0.09919912,0.02374974,0.005909326,0.1027051,0.0008465853,0.05098289],"genre_scores_gemma":[0.02168882,0.6808694,0.09225221,0.06696068,0.007868454,0.01217961,0.1009165,0.0006601326,0.0166041],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0406962,"threshold_uncertainty_score":0.1588637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01860882483650613,"score_gpt":0.2950648817454387,"score_spread":0.2764560569089326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}